Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azficel-T for Restrictive Burn Scars
NCT01858753Phase 2Terminated
- Sponsor
- Castle Creek Biosciences
- Start
- May 2013
- Primary completion
- May 2016
- Modality
- Bone Marrow HSCs, Peripheral Blood HSCs
- Countries
- 1
01
Overview
A Phase 2 trial of azficel-t in burn scar, sponsored by Castle Creek Biosciences. Started May 2013; status: terminated.
02
Drugs
azficel-t
03
Conditions
burn scar
Beyond the preview
Go deeper on NCT01858753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01858753.